Analyst Price Target is $0.22
▲ +162.84% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for THC Biomed Intl in the last 3 months. The average price target is $0.22, with a high forecast of $0.22 and a low forecast of $0.22. The average price target represents a 162.84% upside from the last price of $0.08.
Current Consensus is
The current consensus among 1 investment analysts is to buy stock in THC Biomed Intl.